CompletedNot applicableNCT03793894
Official study title

Inpatient Smokers and LDCT Screening Part 2

Study summary

Lung cancer suffers from large racial and socioeconomic disparities. Yet those at the highest risk of lung cancer death - current smokers, blacks, and individuals with low socioeconomic status (SES) and negative social determinants of health (SDH) - are less likely to receive preventive health services, including the two most effective interventions to reduce lung cancer mortality: tobacco dependence treatment and lung cancer screening (LCS) with low-dose computed tomography (LDCT). At Boston Medical Center (BMC) these preventive services are grossly underutilized, in part due to barriers our patients face in accessing these outpatient programs. Innovative approaches are needed to guide high-risk smokers to post-discharge early lung cancer detection services. The overarching goal of this study is to reduce disparities in lung cancer morbidity and mortality by using hospitalization at an urban safety net hospital as an opportunity to connect high-risk smokers to both LDCT lung cancer screening and tobacco dependence treatment. In addition to inpatient shared decision making \[SDM\] by an NP using a decision aid, screen-eligible smokers will also be connected with a community health worker (CHW) to facilitate access to outpatient smoking cessation counseling and LCS (CHW navigation).

Ask AI to explain this study
Start here

Key things to know

Main goalHealth Services Research

This describes the study’s primary purpose.

What is being studiedSmoking Cessation Counseling and Decision Aid

Plus 2 other study approaches.

Who it may be forLung Cancer Screening · Smoking Cessation

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Jul 7, 2020 · Source: ClinicalTrials.gov

Is enrollment open?Completed

Ask the study team to confirm whether enrollment is open.

What kind of study?Not applicable

Interventional

Where is it offered?1 U.S. location

Locations may change over time.

Who runs it?Boston University

Study sponsor

01
Study overview

What this study is about

Purpose
Health Services Research
Study type
Interventional
Phase
Not applicable
Sponsor
Boston University
Interventions being studied
Behavioral: Smoking Cessation Counseling; Behavioral: Decision Aid; Behavioral: Shared decision making (SDM); Behavioral: CHW Navigation
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

03
Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria

1. Hospitalized smoker at BMC 2. Meeting LDCT screening eligibility criteria: (age 55-80 years; ≥30-pack years smoking) 3. Current smoker (\> 1 cigarette per day) 4. Able to speak, read, and understand English 5. Able and willing to comply with all study protocols and procedures 6. Having a PCP in the BMC network or one of the affiliated health centers

Reasons someone may not be able to joinExclusion criteria

1. Inability to tolerate surgical resection of a lung cancer, as defined by home oxygen therapy (an indicator of severe lung cancer or heart disease) 2. Active cancer (receiving treatment/new diagnosis) in prior 3 months or advanced stage cancer 3. Signs and symptoms of lung cancer or prior diagnosis of lung cancer 4. Already had chest CT (LDCT screening or other chest CT) in the past year 5. Pregnant

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • Boston Medical CenterBoston, Massachusetts

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Jul 7, 2020. Always confirm current availability with the study team.

View original record ↗